首页> 美国卫生研究院文献>Infection Chemotherapy >Antibiotic Control Policies in South Korea 2000-2013
【2h】

Antibiotic Control Policies in South Korea 2000-2013

机译:2000-2013年韩国的抗生素控制政策

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Antibiotic stewardship is a key strategy for limiting antibiotic resistance. Over the last decade the South Korean government has implemented a series of healthcare policies directed to this end, consisting of legislative separation of drug prescribing and dispensing, antibiotic utilization reviews, healthcare quality assessment, and public reporting. As a result, the proportion of antibiotic prescriptions for acute upper respiratory tract infections in primary healthcare facilities decreased from 72.9% in 2002 to 42.7% in 2013. However, no significant decrease in antibiotic resistance occurred over the same period in clinically important bacteria such as Streptococcus pneumoniae. These government-driven policies played a pivotal role in improving antibiotic use for outpatients and surgical patients in South Korea. However, to achieve long-lasting successful outcomes, coordinated efforts and communications among the stakeholders, including physicians and medical societies, are needed.
机译:抗生素管理是限制抗生素耐药性的关键策略。在过去的十年中,韩国政府为此目的实施了一系列医疗保健政策,其中包括将药物处方和配药的立法分开,抗生素利用审查,医疗保健质量评估和公共报告。结果,基层医疗机构中用于急性上呼吸道感染的抗生素处方比例从2002年的72.9%下降到2013年的42.7%。但是,在临床上重要的细菌如肺炎链球菌。这些政府主导的政策在改善韩国门诊和手术患者的抗生素使用中起着关键作用。然而,为了取得持久的成功成果,需要利益相关者(包括医生和医学团体)之间的协调努力和沟通。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号